IMPACT OF REVISION OF THE LR-M CRITERIA ON THE DIAGNOSTIC PERFORMANCE OF CONTRAST-ENHANCED ULTRASOUND LI-RADS

被引:18
作者
Ding, Jianmin [1 ,2 ]
Qin, Zhengyi [1 ]
Zhou, Yan [1 ]
Zhou, Hongyu [1 ]
Zhang, Qin [3 ]
Wang, Yandong [1 ]
Jing, Xiang [1 ]
Wang, Fengmei [4 ]
机构
[1] Tianjin Third Cent Hosp, Tianjin Inst Hepatobiliary Dis, Tianjin Key Lab Artificial Cell, Artificial Cell Engn Technol Res Ctr Publ Hlth Mi, Tianjin, Peoples R China
[2] Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China
[3] Tianjin Third Cent Hosp, Dept Pathol, Tianjin Inst Hepatobiliary Dis, Tianjin Key Lab Artificial Cell,Artificial Cell E, Tianjin, Peoples R China
[4] Tianjin Third Cent Hosp, Tianjin Inst Hepatobiliary Dis, Dept Gastroenterol & Hepatol, Tianjin Key Lab Artificial Cell,Artificial Cell E, Tianjin, Peoples R China
关键词
Hepatocellular carcinoma; Ultrasonography; Contrast agent; Liver cirrhosis; Diagnostic techniques and procedures; HEPATOCELLULAR-CARCINOMA; CIRRHOSIS;
D O I
10.1016/j.ultrasmedbio.2021.08.007
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
This study was aimed at revising the LI-RADS M category (LR-M) criteria to improve the diagnostic performance categories LR-5 and LR-M of the contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) Version 2017. We enrolled 264 patients (264 nodules) with a risk for hepatocellular carcinoma (HCC). The nodules were assigned specific CEUS LI-RADS categories. Washout onset times for all nodules were noted. The diagnostic performance of LR-5 and LR-M was analyzed based on the different early washout criterion for the LR-M category. The positive predictive values in LR-5, LR-4 and LR-3 were 98.6%, 72.2% and 16.7%, respectively, and that for non-HCC malignancies in LR-M was 25.0%. Patients in the LR-M category were reclassified using 45 s as the early washout criterion. LR-5 had higher sensitivity (65.5% vs. 76.2%, p = 0.012) and area under the receiver operating characteristic curve (0.80 vs. 0.85, p = 0.001) for HCC diagnosis after reclassification. LR-M also had higher specificity (71.4% vs. 81.3%, p = 0.010) in diagnosing nonHCC malignancies after reclassification. Our findings suggest CEUS LR-5 is effective for HCC diagnosis. The use of 45 s as the time criterion of early washout for LR-M can improve LR-5 and LR-M performance in the diagnosis of HCC and non-HCC malignancies, respectively. (C) 2021 Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:3403 / 3410
页数:8
相关论文
共 18 条
[1]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[2]   Comparison between M-score and LR-M in the reporting system of contrast-enhanced ultrasound LI-RADS [J].
Chen, Li-Da ;
Ruan, Si-Min ;
Lin, Yuan ;
Liang, Jin-Yu ;
Shen, Shun-Li ;
Hu, Hang-Tong ;
Huang, Yang ;
Li, Wei ;
Wang, Zhu ;
Xie, Xiao-Yan ;
Lu, Ming-De ;
Kuang, Ming ;
Wang, Wei .
EUROPEAN RADIOLOGY, 2019, 29 (08) :4249-4257
[3]   Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS [J].
Ding, Jianmin ;
Long, Lei ;
Zhang, Xiang ;
Chen, Chen ;
Zhou, Hongyu ;
Zhou, Yan ;
Wang, Yandong ;
Jing, Xiang ;
Ye, Zhaoxiang ;
Wang, Fengmei .
EUROPEAN RADIOLOGY, 2021, 31 (02) :847-854
[4]   EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis [J].
Angeli P. ;
Bernardi M. ;
Villanueva C. ;
Francoz C. ;
Mookerjee R.P. ;
Trebicka J. ;
Krag A. ;
Laleman W. ;
Gines P. .
JOURNAL OF HEPATOLOGY, 2018, 69 (02) :406-460
[5]   Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma? [J].
Huang, Jia-Yan ;
Li, Jia-Wu ;
Ling, Wen-Wu ;
Li, Tao ;
Luo, Yan ;
Liu, Ji-Bin ;
Lu, Qiang .
WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (27) :3938-3951
[6]   Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma [J].
Huang, Jia-Yan ;
Li, Jia-Wu ;
Lu, Qiang ;
Luo, Yan ;
Lin, Ling ;
Shi, Yu-Jun ;
Li, Tao ;
Liu, Ji-Bin ;
Lyshchik, Andrej .
RADIOLOGY, 2020, 294 (02) :329-339
[7]   Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JS']JSH-HCC Guidelines) [J].
Kokudo, Norihiro ;
Hasegawa, Kiyoshi ;
Akahane, Masaaki ;
Igaki, Hiroshi ;
Izumi, Namiki ;
Ichida, Takafumi ;
Uemoto, Shinji ;
Kaneko, Shuichi ;
Kawasaki, Seiji ;
Ku, Yonson ;
Kudo, Masatoshi ;
Kubo, Shoji ;
Takayama, Tadatoshi ;
Tateishi, Ryosuke ;
Fukuda, Takashi ;
Matsui, Osamu ;
Matsuyama, Yutaka ;
Murakami, Takamichi ;
Arii, Shigeki ;
Okazaki, Masatoshi ;
Makuuchi, Masatoshi .
HEPATOLOGY RESEARCH, 2015, 45 (02) :123-127
[8]   Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®): the official version by the American College of Radiology (ACR) [J].
Kono, Yuko ;
Lyshchik, Andrej ;
Cosgrove, David ;
Dietrich, Christoph F. ;
Jang, Hyun-Jung ;
Kim, Tae Kyoung ;
Piscaglia, Fabio ;
Willmann, Juergen K. ;
Wilson, Stephanie R. ;
Santillan, Cynthia ;
Kambadakone, Avinash ;
Mitchell, Donald ;
Vezeridis, Alexander ;
Sirlin, Claude B. .
ULTRASCHALL IN DER MEDIZIN, 2017, 38 (01) :85-86
[9]   Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017 [J].
Li, Fei ;
Li, Qing ;
Liu, Yubo ;
Han, Jing ;
Zheng, Wei ;
Huang, Yini ;
Zheng, Xueyi ;
Cao, Longhui ;
Zhou, Jian-hua .
EUROPEAN RADIOLOGY, 2020, 30 (01) :461-470
[10]   The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system [J].
Li, JiaWu ;
Ling, WenWu ;
Chen, Shuang ;
Ma, Lin ;
Yang, Lulu ;
Lu, Qiang ;
Luo, Yan .
EUROPEAN JOURNAL OF RADIOLOGY, 2019, 120